These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Rivaroxaban or Enoxaparin in Nonmajor Orthopedic Surgery. Samama CM; Laporte S; Rosencher N; Girard P; Llau J; Mouret P; Fisher W; Martínez-Martín J; Duverger D; Deygas B; Presles E; Cucherat M; Mismetti P; N Engl J Med; 2020 May; 382(20):1916-1925. PubMed ID: 32223113 [TBL] [Abstract][Full Text] [Related]
10. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Kakkar AK; Brenner B; Dahl OE; Eriksson BI; Mouret P; Muntz J; Soglian AG; Pap AF; Misselwitz F; Haas S; Lancet; 2008 Jul; 372(9632):31-9. PubMed ID: 18582928 [TBL] [Abstract][Full Text] [Related]
11. [Adherence to and satisfaction with oral outpatient thromboembolism prophylaxis compared to parenteral: SALTO study]. Peidro-Garcés L; Otero-Fernandez R; Lozano-Lizarraga L Rev Esp Cir Ortop Traumatol; 2013; 57(1):53-60. PubMed ID: 23594983 [TBL] [Abstract][Full Text] [Related]
12. A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement. Eriksson BI; Borris LC; Dahl OE; Haas S; Huisman MV; Kakkar AK; Muehlhofer E; Dierig C; Misselwitz F; Kälebo P; Circulation; 2006 Nov; 114(22):2374-81. PubMed ID: 17116766 [TBL] [Abstract][Full Text] [Related]
13. Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol. Cohen AT; Spiro TE; Büller HR; Haskell L; Hu D; Hull R; Mebazaa A; Merli G; Schellong S; Spyropoulos A; Tapson V J Thromb Thrombolysis; 2011 May; 31(4):407-16. PubMed ID: 21359646 [TBL] [Abstract][Full Text] [Related]
14. Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery. Quinlan DJ; Eriksson BI Best Pract Res Clin Haematol; 2013 Jun; 26(2):171-82. PubMed ID: 23953905 [TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Novel Oral Anticoagulants vs Low Molecular Weight Heparin for Thromboprophylaxis in Large-Volume Liposuction and Body Contouring Procedures. Morales R; Ruff E; Patronella C; Mentz H; Newall G; Hustak KL; Fortes P; Bush A Aesthet Surg J; 2016 Apr; 36(4):440-9. PubMed ID: 26961988 [TBL] [Abstract][Full Text] [Related]
16. Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies. Fisher WD; Eriksson BI; Bauer KA; Borris L; Dahl OE; Gent M; Haas S; Homering M; Huisman MV; Kakkar AK; Kälebo P; Kwong LM; Misselwitz F; Turpie AG Thromb Haemost; 2007 Jun; 97(6):931-7. PubMed ID: 17549294 [TBL] [Abstract][Full Text] [Related]
17. Thromboprophylaxis after minimally invasive total knee arthroplasty: a comparison of rivaroxaban and enoxaparin. Yen SH; Lin PC; Kuo FC; Wang JW Biomed J; 2014; 37(4):199-204. PubMed ID: 25116715 [TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism prophylaxis in the massive weight loss patient: relative risk of bleeding. Michaels J; Coon D; Mulvey CL; Rubin JP Ann Plast Surg; 2015 Jun; 74(6):699-702. PubMed ID: 24727447 [TBL] [Abstract][Full Text] [Related]
19. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal. Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028 [TBL] [Abstract][Full Text] [Related]
20. Oral direct factor Xa inhibitor gets FDA's OK. Thompson CA Am J Health Syst Pharm; 2011 Aug; 68(16):1467. PubMed ID: 21817076 [No Abstract] [Full Text] [Related] [Next] [New Search]